Edition:
United Kingdom

Recro Pharma Inc (REPH.OQ)

REPH.OQ on NASDAQ Stock Exchange Capital Market

7.87USD
10 Dec 2018
Change (% chg)

-- (--)
Prev Close
$7.87
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
37,993
52-wk High
$13.05
52-wk Low
$4.78

Chart for

About

Recro Pharma, Inc. is a clinical-stage specialty pharmaceutical company. The Company is engaged in developing products for hospitals and ambulatory care settings that is developing non-opioid products for treatment of serious acute pain. The Company's lead product candidate is an injectable form of meloxicam. Its product... (more)

Overall

Beta: -0.54
Market Cap(Mil.): $171.73
Shares Outstanding(Mil.): 19.06
Dividend: --
Yield (%): --

Financials

  REPH.OQ Industry Sector
P/E (TTM): -- 92.25 33.63
EPS (TTM): -2.17 -- --
ROI: -23.45 0.28 15.02
ROE: -74.12 0.94 16.60

Earnings vs. Estimates